Warm Greetings!
Welcome to yet another exciting month and pleasant reading of our newsletter.
Makers of inhalers to treat asthma and chronic lung disease are racing to develop a new generation of smart devices with sensors to monitor if patients are using their puffers properly.
Linked wirelessly to the cloud, the gadgets are part of a medical “Internet of Things” that promises improved adherence, or correct use of the medication, and better health outcomes. They may also hold the key to company profits in an era of increasingly tough competition.
Drugmakers believe giving patients and doctors the ability to check inhaler use in this way could be a big help in proving the value of their medicines to governments and insurers, though they need to tread carefully on data privacy.
Do not hesitate to mail your comments on this edition to help us further improve. We appreciate your support and trust in us and are happy to have you as our loyal reader.
Feedback is what keeps us going. Should you have any query or question, please feel free to get in touch with us. Write to me on pyush@jagograhakjago.com
You may find our previous issues on our website jagograhakjago.com or in the NEWS ARCHIVE section of every issue of The Prescription, in case you’ve missed any of them. You may also look us up on Facebook.
Stay Healthy. Stay Protected.
Pyush Misra
Editor-in-Chief,
The Prescription
The 'Mukhya Mantri Jan Arogya Abhiyan' will benefit nearly a million households or 5.6 million bottom of pyramid beneficiaries deprived of Ayushman Bharat-National Health Protection Mission Scheme (NHPMS). We are making use of modern technology, such as telemedicine to reach out to the remote areas for providing medical and healthcare facilities.
Swami Yogi Adityanath
Chief Minister, Uttar Pradesh
The June quarter results of Indian pharmaceutical firms were encouraging, reflecting that the top companies are on a path to recovery. First quarter FY20 revenues of 10 leading pharma firms rose by about 13.3% from the year-ago quarter. They also focused on cost control, which resulted in Ebitda margins expanding by 98 basis points year-on-year to 20.7%. Ebitda is earnings before interest, taxes, depreciation and amortization. Net profit of these companies rose 22.7%.
Stem Cell And Gene Therapy Online Ads For 'Unproven' Therapies Are Banned By Google
San Francisco, 7 Sept 2019: Google said on Friday that it was banning online ads for unproven medical treatments including most stem cell and gene therapy.
China Expands Drug Bulk-Buy Programme, Puts Pressure On Pharma Firms
Bejing, 2 Sept 2019: China has expanded a pilot drug bulk-buying programme to almost the entire country in an attempt to negotiate lower prices from drug manufacturers, heaping fresh pressure on multinational pharmaceutical companies and their domestic rivals.
Serious Liver Injury Tied To HCV Drugs In Rare Cases, US FDA Warns
Maryland, 29 Aug 2019: The US Food and Drug Agency (FDA) warned on Wednesday that three direct-acting antiviral drugs have been associated with rare cases of severe liver injury in patients being treated for chronic hepatitis C virus (HCV) infection.
China Revises Law, Opens Door To Cheap Indian Generic Medicines Too
Beijing, 27 Aug 2019: Generic drugs approved in India and other countries but not in China have been removed from the country’s “fake medicine” list and can be used by patients in small quantities from December 1, the newly revised drug administration law of the country says. Until now, all foreign generic drugs not approved in China were clubbed under the counterfeit category and were illegal to use here.
LA City Attorney Files Charges In 2 Different Counterfeit/Misbranded Prescription Drug Cases
September 6, 2019: On August 21, LA City Attorney Mike Feuer announced two separate cases had resulted in charges. In the first, criminal charges have been filed against eight people for allegedly importing more than 100,000 units of non-FDA approved pharmaceuticals, and selling them in the local area on the street in front of local businesses. In a second case, Feuer’s office seized a website offering illegal, misbranded, and counterfeit medications for sale online.
Economic Policy Researcher Finds Fault With Federal Drug Importation Plans
August 30, 2019 : This editorial by Liam Sigaud was published by Inside Sources on August 27, 2019. Mr. Sigaud writes for the American Consumer Institute, a nonprofit educational and research organization.
Frequently Asked Questions
6 essential oils for anxiety you should try
If you experience anxiety, there are several essential oils that could help you, whether you experience it on a daily basis or just occasionally. They not only smell incredible but these aromas can have a hugely positive effect too when you add a few drops to your bath water, spray some onto your pillow or apply them topically onto your skin. Read More>>>
Shocking: How Implant In Hip Led To A Heart Attack
New Delhi, 4 Sept 2019: A man with a broken hip who had undergone multiple surgeries was diagnosed with an unusual complication at the AIIMS Trauma Centre recently. The doctors found that the 37-year-old had suffered a serious damage to the heart muscles due to the increased toxicity after the use of a cobalt-chromium implant in a revision surgery.
Ms Monica Trivedi, IT ProfessionalAlways look forward to the newsletter editions every month for an interesting read. Great work PSM India!
Ms Doris D'Souza, Professional "The Prescription" is a much awaited dose for my monthly consumption of important pharma developments and news. Well done!
F-9, 2nd floor, Kailash Colony, New Delhi -110048
jagograhakjago.com; www.jagograhakjago.com;
Disclaimer : Our newsletter endeavors to compile patient safety information from various sources . PSM India may not be held responsible for any article published in The Prescription.